The fastest-growing vertical in synthetic biology. Protein language models are doing for biology what LLMs did for language — enabling de novo protein design, virtual cell simulations, and autonomous lab operations.
| Company | Category | Product | Stage | Funding |
|---|---|---|---|---|
| EvolutionaryScale | Protein Language Models | ESM-3, ESM-4 | Commercial | $540M |
| Cradle | Protein Language Models | Cradle AI platform | Commercial | $73M |
| Absci | Generative Drug Design | Integrated Drug Creation | Clinical | Public (ABSI) |
| Arzeda | Computational Protein Design | Enzyme engineering | Commercial | $40M+ |
| Recursion | Virtual Cell Models | Phenomics + LLMs | Clinical | Public (RXRX) |
| Synthace | Lab Automation | Antha platform | Commercial | $90M+ |
| Strateos | Cloud Labs | Robotic cloud lab | Commercial | $60M+ |
| Generate Biomedicines | Generative Biology | AI-designed proteins | Clinical | $370M+ |